Coming Out of the Dark: Advances in Migraine Care

Conflict of Interest Disclosure Statement

The “Policy on Identification, Mitigation and Disclosure of Relevant Financial Relationships” of Albert Einstein College of Medicine-Montefiore Medical Center (Einstein-Montefiore) requires that faculty, and all individuals in a position to control the educational content of an accredited activity, disclose all financial relationships with ineligible companies* within the 24 months prior to their involvement in the activity. Einstein-Montefiore resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational activities. All relevant financial relationships and potential conflicts of interest are mitigated prior to the activity. Any faculty or individual whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.

*The ACCME defines an ineligible company as those whose primary business is producing, marketing, re-selling or distributing healthcare products used by or on patients.

Disclosure of Unlabeled Use

Albert Einstein College of Medicine-Montefiore Medical Center requires that faculty participating in any CME/CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device, not yet approved in the United States.

Summary of Individual Disclosures for Faculty and Planners

Credit Designation Statement

Albert Einstein College of Medicine-Montefiore Medical Center designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Statement– CME Provider

In support of improving patient care, Albert Einstein College of Medicine-Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Accreditation Statement – AANP Provider

National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.5 Contact hour (which includes 0.5 hours of pharmacology).

Policy on Faculty and Provider Disclosure

Educational programs sponsored by the National Association for Continuing Education (NACE) must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a NACE-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity. Any potential conflicts of interest will be resolved prior to the activity.

Per the ACCME, a Commercial Interest is defined as an entity producing, marketing, re-selling or distributing health care goods or services consumed by or used on, patients. Providers of clinical service directly to patients are not considered to be commercial interests - unless the provider of the clinical service is owned, or controlled by, a defined commercial interest.

COMMERCIAL SUPPORT STATEMENT

This activity is supported by educational funding provided by Amgen and educational funding provided by Biohaven Pharmaceuticals.